In our study, in addition to the laboratory abnormalities usually observed in these patients, we compared two other biomarkers: procalcitonin (PCT) and MR-pro adrenomedullin (ADM), two biomarkers that have previously shown utility in the diagnosis of sepsis [17, 32]. The gene discussed is ADM; the disease is Sepsis.